Health News Releases

  • Today March 20
January 21, 11:30
Biocytogen and Acepodia Join Forces to Advance Bispecific Antibody and Dual-Payload ADCs for Treating Complex Tumors
Biocytogen (HKEX: 02315) and Acepodia (6976:TT), today announced a groundbreaking strategic partnership to jointly assess a dual-payload bispecific antibody-drug conjugate (BsAD2C) program. This co
Novotech Triple Negative Breast Cancer Clinical Trial Report
January 17, 14:30
Novotech Releases Report on Current State of Triple-Negative Breast Cancer Clinical Trials
Novotech, the leading global full-service clinical Contract Research Organization (CRO), has released a comprehensive report analyzing the global clinical trial and drug development landscape for Trip
January 17, 08:47
SINOVAC Issues Statement Regarding Privy Council Judgment
Sinovac Biotech Ltd. (NASDAQ:SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that the Judicial Committee of the Privy Council in London, E
January 15, 11:15
Mesmerise to collaborate with Mayo Clinic to Transform Medical Education and Healthcare Workforce Training
Mesmerise is proud to announce the creation of NeuRealities, Inc., a transformative company designed to revolutionize medical education and healthcare training. As part of a know-how agreement with Ma
January 14, 16:20
Galderma Premieres Positive Interim Results Demonstrating the Efficacy of Its Injectable Aesthetics Portfolio in Addressing Facial Volume Loss as a Result of Medication-driven Weight Loss
Galderma (SWX:GALD) announces positive first results from a trial designed to explore the benefits of Restylane® Lyft™ or Contour™ in combination with Sculptra® in patients with medication-driven weig
January 14, 16:10
Zepp Health to Showcase Groundbreaking Innovations at CES Pepcom & ShowStoppers Media Events
--CES -- Zepp Health Corporation (NYSE: ZEPP), a global leader in health technology and smart wearables, is thrilled to announce its participation in the CES Pepcom and ShowStoppers media events. Thes
January 12, 12:35
Biocytogen Announces Licensing of Fully Human Antibodies with SOTIO to Develop Novel ADC SOT109 for Colorectal Cancer Treatment
Biocytogen (HKEX: 02315) (https://en.biocytogen.com.cn/), a global biotech company dedicated to discovering and developing novel antibody therapeutics, announced the licensing of its fully human antib
In a landmark step towards advancing cancer care in the Middle East, BOSTON ONCOLOGY ARABIA and SPIM
January 10, 11:05
BOSTON ONCOLOGY ARABIA and SPIMACO Partner to Localize Advanced Oral Oncology Treatments in Saudi Arabia
In a landmark step towards advancing cancer care in the Middle East, BOSTON ONCOLOGY ARABIA and SPIMACO have signed a Memorandum of Understanding (MoU) to localize the production of advanced oral onco
January 08, 10:35
Parse Biosciences Quadruples Sample Multiplexing Abilities for Evercode WT Mega Kits
Parse Biosciences, a leader in accessible and scalable single cell sequencing solutions, today announced a significant expansion of its Evercode™ WT Mega Kit (https://cts.businesswire.com/ct/CT?id=sma
January 07, 10:09
Avenacy Provides Update on 2025 Strategic Priorities Ahead of 43rd Annual J.P. Morgan Healthcare Conference
Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, today provided an update on recent business highlights and financial performance for 2024 and strategi
January 02, 09:03
Takeda Announces Approval of HYQVIA® 10% S.C. (Subcutaneous) Injection Set in Japan for Patients with Agammaglobulinemia or Hypogammaglobulinemia
Takeda (TSE:4502/NYSE:TAK (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.takeda.com%2Finvestors%2F&esheet=54169696&newsitemid=20241219442534&lan=en-US&anchor=%28TSE%3A4502%2FNY
December 24, 2024 10:35
BeiGene to Change Nasdaq Ticker Symbol to “ONC” on January 2; Present at 43rd Annual J.P. Morgan Healthcare Conference
BeiGene (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.beigene.com%2F&esheet=54170287&newsitemid=20241223168194&lan=en-US&anchor=BeiGene&index=1&md5=7a7ba2e89608bb25a23fb84e5c3
December 24, 2024 10:30
Biocytogen Announces Adcendo ApS Exercises Antibody Option to Accelerate ADC Development
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315), a global biotech company focusing on the discovery of novel antibody/ADC therapeutics, announced that Adcendo ApS (“Adcendo”),
December 24, 2024 09:46
Fujirebio and Eisai Enter into Memorandum of Understanding for Joint Research and Social Implementation of Blood-based Biomarkers in the Field of Neurodegenerative Diseases
Fujirebio Holdings, Inc. (President & CEO: Goki Ishikawa; Head Office: Minato-ku, Tokyo), a wholly-owned subsidiary of H.U. Group Holdings, Inc. (Chairman, President and Group CEO: Shigekazu Takeuchi;
Aster Guardians Global Nursing Award worth USD $250,000 (Photo: AETOSWire)
December 23, 2024 15:35
Aster Guardians Global Nursing Award 2025 Worth US$250,000 Now Open for Nominations Worldwide
Aster DM Healthcare has announced the fourth edition of the Aster Guardians Global Nursing Award, inviting nurses worldwide to apply for the prestigious USD 250,000 prize. The award recognizes excepti
December 23, 2024 14:45
SBC Medical Group Co., Ltd. Sells Two Subsidiaries
On December 17, 2024, SBC Medical Group Holdings Incorporated (“SBC Medical”, or the “Company”), announced that its subsidiary, SBC Medical Group Co., Ltd. (hereinafter referred to as “SBCMG”), has de
December 20, 2024 09:50
ClinChoice Extends 13-Year Medidata Partnership with the Addition of Clinical Data Studio to Improve Data Management and Strengthen Clinical Trial Capabilities
Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, has renewed its long-standing enterprise partnership with ClinChoice (https://cts.bu
GC Aesthetics’ PERLE™ Breast Implant features a proprietary surface technology (BioQ™) and GCA’s ind
December 19, 2024 14:50
GC Aesthetics® Announces Decade-Long Clinical Evaluation of PERLE™ Breast Implants
GC Aesthetics® (GCA), a privately-held medical technology company providing aesthetic and reconstruction solutions for global healthcare markets, is proud to announce the initiation of a significant m
December 19, 2024 13:40
Novotech Releases Report on Global Parkinson’s Disease Clinical Trial Landscape
Novotech, the global full-service clinical Contract Research Organization (CRO), announces the release of its report, Parkinson’s Disease: Global Clinical Trial Landscape 2024 (https://cts.businesswir
December 19, 2024 10:30
Novotech Publishes Report on the Global COVID-19 Clinical Trial Landscape, Highlighting Key Trends, Therapeutic Advancements, and Challenges in Drug Development
Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics, has released an i
(Photo: Business Wire)
December 18, 2024 15:50
Carestream Secures Crucial Business Partner Agreement in Algeria
Carestream Health recently secured an agreement with BSF Medical - SARL, a leading distributor of medical solutions covering cardiology, urology, endoscopy, radiology, and pharmaceutical products in A
December 18, 2024 14:30
Biocodex Strengthens Supply Chain Resilience with Kinaxis
Biocodex (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.biocodex.com%2Fen%2F&esheet=54166747&newsitemid=20241216873592&lan=en-US&anchor=Biocodex&index=1&md5=b3bef2f213ddbbd3737
December 18, 2024 13:40
SINOVAC Initiated a Phase III Clinical Trial on Bivalent Vaccine Against Hand Foot and Mouth Disease (HFMD)
Sinovac Biotech Ltd. (“SINOVAC” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today kicked off the enrollment for a Phase III clinical trial on a vaccine
December 17, 2024 11:20
HistoSonics Edison® Histotripsy System Treats First Pancreatic Tumor Patients in GANNON Trial
HistoSonics (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fhistosonics.com%2F&esheet=54166940&newsitemid=20241216604376&lan=en-US&anchor=HistoSonics&index=1&md5=035f1602d28e12cb40e
Clinical Trial Management Award for Novotech (Graphic: Business Wire)
December 17, 2024 09:35
Novotech Named a Fierce CRO Award Winner in the Excellence in Clinical Trial Management and Global Operations Categories
Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech and small to mid-size pharma companies to accelerate the development of advanced and novel th
25 per page50 per page75 per page100 per page